When a Seizure Strikes, Are Your Patients Prepared?
A complete Seizure Preparedness Plan can help your patients live life with less fear and uncertainty. Download a plan now.
A complete Seizure Preparedness Plan can help your patients live life with less fear and uncertainty. Download a plan now.
Professionals Share Their Experiences with DIASTAT®AcuDial™ (diazepam rectal gel)
Lora Morn, RN: Seizure TriggersSue Yudovin, RN: Seizure Plans
Kathryn O'Hara, RN: Summer Travel Planning
Jong Rho, MD: Seizure Preparedness Plans
IMPORTANT SAFETY INFORMATION
DIASTAT® AcuDial™ (diazepam rectal gel) is a gel formulation of diazepam intended for rectal administration in the management of selected, refractory patients with epilepsy, on stable regimens of AEDs, who require intermittent use of diazepam to control bouts of increased seizure activity for patients 2 years and older.
In clinical trials with DIASTAT®, the most frequent side effect was somnolence (23%). Less frequent adverse events reported were dizziness, headache, pain, vasodilation, diarrhea, ataxia, euphoria, incoordination, asthma, rash, abdominal pain, nervousness and rhinitis (1%-5%). Please see full DIASTAT AcuDial Prescribing Information.
DIASTAT® AcuDial™ (diazepam rectal gel) is a gel formulation of diazepam intended for rectal administration in the management of selected, refractory patients with epilepsy, on stable regimens of AEDs, who require intermittent use of diazepam to control bouts of increased seizure activity for patients 2 years and older.
In clinical trials with DIASTAT®, the most frequent side effect was somnolence (23%). Less frequent adverse events reported were dizziness, headache, pain, vasodilation, diarrhea, ataxia, euphoria, incoordination, asthma, rash, abdominal pain, nervousness and rhinitis (1%-5%). Please see full DIASTAT AcuDial Prescribing Information.
© Valeant Pharmaceuticals North America 2007
Legal and Privacy Statement
DIASTAT® AcuDial™ is a registered trademark of Valeant Pharmaceuticals North America. D896-0607 Site Map